Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family...

Australian Federal Government Funds Trial of MDMA-Assisted Therapy for Individuals Affected...

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in...

The Church of the Eagle and the Condor Settles with Federal...

Early Research, Psychedelics in Palliative Care, and the Intersection of Science...

FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early...

Music for Psychedelic Exploration and the First ‘Choose Your Own Adventure’...

Reunion Neuroscience Gets a New Lease of Life with $103M Series...

Avoid These Psychedelic Mistakes: How to Stop a Bad Trip Before...

The Veteran Community and Operator Syndrome: Psychedelics and Redefining Pain Management

1...202122...217 Page 21 of 217

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin